ARTICLE | Company News
CAFC halts IPR proceedings while Mohawk tribe, Allergan appeal
March 30, 2018 3:34 PM UTC
The U.S. Court of Appeals for the Federal Circuit (CAFC) ordered the Patent Trial and Appeal Board to stay its inter partes review of patents covering Restasis cyclosporine from Allergan plc (NYSE:AGN) until CAFC hears arguments regarding an appeal of PTAB's decision to deny Saint Regis Mohawk tribe's assertion of sovereign immunity. The reprieve remains in place until the day after oral arguments in the appeal case, scheduled for June. PTAB had scheduled its final IPR hearing for April 3.
PTAB ruled last month that Allergan could not skirt an IPR challenging its Restasis patents by transferring the patents to the tribe (see BioCentury, March 1)...